Peptic Ulcer Disease (PUD) remains a prevalent gastrointestinal disorder with significant morbidity and mortality. As healthcare professionals, it is vital to adopt a comprehensive approach to its management to achieve optimal patient outcomes.
Understanding the pathophysiology of PUD is key to effective management. It involves an imbalance between the aggressive factors (H. pylori, NSAIDs, acid, pepsin) and defensive mechanisms (mucus, bicarbonate, blood flow, prostaglandins) of the gastric mucosa.
Accurate diagnosis and risk stratification are essential. This includes history taking, physical examination, laboratory tests, and endoscopy. High-risk features such as age over 60, presence of alarm symptoms, and NSAID use should prompt urgent endoscopy.
Treatment involves eradicating H. pylori, if present, with a regimen of proton pump inhibitors and antibiotics. For NSAID-induced ulcers, discontinuation of NSAIDs and long-term PPI therapy is recommended. In refractory cases, surgery may be necessary.
Prevention strategies include judicious use of NSAIDs, H. pylori screening and eradication, and patient education. Regular follow-up is crucial to assess treatment response, monitor for complications, and ensure adherence to therapy.
In conclusion, effective management of PUD requires a comprehensive approach that encompasses a thorough understanding of the pathophysiology, accurate diagnosis and risk stratification, appropriate treatment strategies, and vigilant prevention and follow-up. By adopting such an approach, healthcare professionals can significantly improve the outcomes and quality of life of patients with PUD.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation